| Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy |
28 |
| Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab |
24 |
| Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma |
24 |
| Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer |
13 |
| Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study |
11 |
| High Expression of Vimentin is Associated With Progression and a Poor Outcome in Glioblastoma |
10 |
| Human Endometriosis Tissue Microarray Reveals Site-specific Expression of Estrogen Receptors, Progesterone Receptor, and Ki67 |
9 |
| Optical Biomarker-based Biosensors for Cancer/Infectious Disease Medical Diagnoses |
8 |
| Characterization of PD-L1 Immunohistochemical Expression in Cell Blocks With Different Specimen Fixation and Processing Methods |
8 |
| Prognostic Significance of Stromal Versus Intratumoral Infiltrating Lymphocytes in Different Subtypes of Breast Cancer Treated With Cytotoxic Neoadjuvant Chemotherapy |
7 |
| Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP) |
7 |
| Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma |
7 |
| A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification |
6 |
| Immunohistochemical Detection of gamma/delta T Lymphocytes in Formalin-fixed Paraffin-embedded Tissues |
6 |
| BRAF V600E Mutation Across Multiple Tumor Types: Correlation Between DNA-based Sequencing and Mutation-specific Immunohistochemistry |
6 |
| HER2 Status in Gastric and Gastroesophageal Junction Cancer: Results of the Large, Multinational HER-EAGLE Study |
6 |
| Somatic Mutations and Intratumoral Heterogeneity of MYH11 Gene in Gastric and Colorectal Cancers |
5 |
| Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin |
5 |
| Small Biopsies Misclassify up to 35% of PD-L1 Assessments in Advanced Lung Non-Small Cell Lung Carcinomas |
5 |
| Diagnostic Utility of Pax Pax and NGFR Immunohistochemical Expression in Pediatric Renal Tumors |
5 |
| Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and Diagnosis |
5 |
| SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma |
5 |
| Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing |
5 |
| Expression of TLE-1 and CD99 in Carcinoma: Pitfalls in Diagnosis of Synovial Sarcoma |
5 |
| AQP1 and AQP3 Expression are Associated With Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma |
4 |
| IgG4 Expression in Primary Cutaneous Marginal Zone Lymphoma: A Multicenter Study |
4 |
| Apoptosis as a Prognostic Factor in Colorectal Carcinoma: Comparison of TUNEL Method and Immunohistochemical Expression of Caspase-3 |
4 |
| A Root Cause Analysis Into the High Error Rate in Clinical Immunohistochemistry |
4 |
| Lymphocyte-to-Monocyte Ratio May Serve as a Better Prognostic Indicator Than Tumor-associated Macrophages in DLBCL Treated With Rituximab |
4 |
| A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors |
4 |
| Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology |
4 |
| Virtual Double Staining: A Digital Approach to Immunohistochemical Quantification of Estrogen Receptor Protein in Breast Carcinoma Specimens |
4 |
| The Multiple Faces of Programmed Cell Death Ligand 1 Expression in Malignant and Nonmalignant Cells |
4 |
| RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry |
4 |
| Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast Cancer |
4 |
| MCM3: A Novel Proliferation Marker in Oral Squamous Cell Carcinoma |
4 |
| A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck |
4 |
| The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma |
4 |
| Downregulation of ADAMTS18 May Serve as a Poor Prognostic Biomarker for Cervical Cancer Patients |
3 |
| Differential Expression of Cytochrome C Oxidase Subunit I Along the Colorectal Adenoma: Carcinoma Progression |
3 |
| Diagnostic Utility of PD-L1 Expression in Lung Adenocarcinoma: Immunohistochemistry and RNA In Situ Hybridization |
3 |
| nCounter NanoString Assay Shows Variable Concordance With Immunohistochemistry-based Algorithms in Classifying Cases of Diffuse Large B-Cell Lymphoma According to the Cell-of-Origin |
3 |
| Overexpression of TACC3 in Breast Cancer Associates With Poor Prognosis |
3 |
| Renal Cell Carcinoma With Leiomyomatous Stroma: A Group of Tumors With Indistinguishable Histopathologic Features, But 2 Distinct Genetic Profiles: Next-Generation Sequencing Analysis of 6 Cases Negative for Aberrations Related to the VHL gene |
3 |
| A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer |
3 |
| NordiQC Assessments of PAX8 Immunoassays |
3 |
| Histologic Features Do Not Reliably Predict Mismatch Repair Protein Deficiency in Colorectal Carcinoma: The Results of a 5-Year Prospective Evaluation |
3 |
| Comparison of Epidermal Growth Factor Receptor Gene Mutations Identified Using Pleural Effusion and Primary Tumor Tissue Samples in Non-Small Cell Lung Cancer |
3 |
| Comparison of beta-Catenin and LEF1 Immunohistochemical Stains in Desmoid-type Fibromatosis and its Selected Mimickers, With Unexpected Finding of LEF1 Positivity in Scars |
3 |
| Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors: A Short Review |
3 |
